Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.
Price updated todayFinancials updated Oct 23, 2026
Explore stock sections · swipe left or right
DOC · Price history
Price at last available close
$19.02
−$1.08 (-5.37%) 1M
2026-10-27
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
Healthpeak Properties, Inc. is an S&P 500 constituent operating as a fully integrated real estate investment trust (REIT). The firm is dedicated to the acquisition, management, and development of premier properties essential for both medical research and the provision of healthcare services.
How they make money
Healthpeak Properties, Inc. operates as a real estate investment trust (REIT) that generates revenue primarily through the ownership, operation, and development of healthcare-related real estate. The company leases its properties to healthcare providers and research institutions, collecting rental income under long-term contractual agreements while managing property-level operational costs.
Products & services
The company provides real estate infrastructure for healthcare discovery and delivery, specifically focusing on outpatient medical facilities, life science laboratory spaces, and continuing care retirement communities (CCRCs).
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
No reconciled product or operating-segment revenue breakdown is available for the current research period. Company-wide revenue remains separate from segment disclosure.
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
The company's revenue is derived from a diverse base of tenants in the healthcare sector; no single tenant accounts for a majority of total revenue as of the fiscal year ended December 31, 2025.
Suppliers, materials & equipment
Property management and maintenance service providers — Various third-party vendors providing facility maintenance, security, and property management services.Source
Strengths
Diversified portfolio across outpatient medical, lab, and CCRC segmentsSource
Strategic focus on high-barrier-to-entry healthcare real estate marketsSource
Risks
Tenant credit risk and potential for operator financial distressSource
Sensitivity to interest rate fluctuations and capital market conditionsSource
Regulatory changes affecting healthcare reimbursement and government fundingSource
Overall investment score · Quality, value, risk and opportunity
28
Poor
PoorElite
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
31
Poor
Financial Strength
32
Business Quality / Moat
28
Management
17
Growth Quality
36
Risk / Durability
54
Weak Company · Expensive Stock
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
28
Avoid
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
35/100
Building Historical Record
Model Score 35/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.
At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.
The model outlook is currently cautious.
What we like
•Recent buyback activity is present
What to watch
•Elevated debt risk
•Valuation is a weaker part of the current profile
•Revenue fundamentals are weak
•Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for DOC
Research inputs 100% complete
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
•Can DOC maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
•Is DOC's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
•Is DOC's debt load manageable relative to cash generation, interest costs and upcoming maturities?
•What future growth or profitability would be needed to justify DOC's current valuation?
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
Volatility = How violently is it moving?
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for DOC
Detected from reported data — verify before acting.
Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Elevated debt risk
Total debt is at least one year of revenue • Interest coverage is below 2x • Cash covers less than 20% of total debt
Community Sentiment
0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)
No personal call yet on DOC.
Potential upside factors
+Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
+Diversified portfolio across outpatient medical, lab, and CCRC segments.
+Strategic focus on high-barrier-to-entry healthcare real estate markets.
+Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
−Debt risk (elevated): Total debt is at least one year of revenue.
−Interest coverage is below 2x.
−Cash covers less than 20% of total debt.
−Tenant credit risk and potential for operator financial distress.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdown
Wall Street Score
Weak28/ 100
Weak (0–50)Fair (51–71)Strong (72+)
Debt
Poor
26
Debt Cost2.9%
Debt Reduction YoY-15.7%
Debt / Equity1.39x
Tap for breakdown →
Revenue
Poor
23
Revenue YoY4.5%
Revenue CAGR13.8%
Net Margin8.6%
Tap for breakdown →
Asset
Fair
55
Asset Growth YoY2.0%
Liquidation/Share$13.65
Net Assets/MCap0.86x
Tap for breakdown →
Capital
Poor
13
Earnings Yield1.9%
Buyback Yield0.7%
Debt Cost2.9%
Tap for breakdown →
Management
Poor
17
ROIC3.0%
ROE3.2%
ROA1.2%
Tap for breakdown →
Moat
Poor
28
EPS Growth-48.5%
FCF/Share Growth3.4%
Rev/Share Growth3.2%
Tap for breakdown →
Valuation
Poor
0
Intrinsic Value$10.71
Value Reference$6.42
MOS-79.8%
Tap for breakdown →
Buffett
Poor
26
Revenue23
Moat28
Valuation0
Tap for breakdown →
MOS
Poor
0
MOS %-79.8%
Value Reference$6.42
Deep Discount Reference$4.28
Tap for breakdown →
Financial
Fair
54
Interest Coverage1.8x
ROIC3.0%
FCF Yield9.4%
Tap for breakdown →
Master
Weak
42
Financial54
Valuation0
Debt26
Tap for breakdown →
Resilience
Strong
73
Survival Years12.9 yrs
Current Ratio1.09x
FCF Margin44.4%
Tap for breakdown →
Was this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
YesNot yetDismiss
Score Changes
8 historical score records available
Previous Score
27
Oct 1, 2026
Change
+0.2
points
Current Score
28
Oct 23, 2026
Category Changes
Revenue+0.2
Debt0
Assets+1.0
Capital+1.0
Management0
Moat0
Valuation0
Buffett+0.2
DOC increased 0.2 points because overall fundamentals improved.
Projected Score
Projected Score
32
Projected Change
+4.4 points
Preliminary comparable-period financial changes suggest improvement of approximately 4.4 points. This is a projected estimate, not the official WallStreetScore.
Monetary values in USD. Share counts in raw units.
Income StatementBalance SheetCash Flow
AnnualQuarterlyTTM + Annual
All rows
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
Line Item
TTM
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
$2.95B
$2.82B
$2.70B
$2.18B
····
····
····
····
····
····
····
Cost of Revenue
$2.88B
$2.19B
$1.07B
$902.1M
····
····
····
····
····
····
····
Gross Profit
$74.7M
$634.5M
$1.63B
$1.28B
····
····
····
····
····
····
····
Research & Development
$0.00
$0.00
$0.00
$0.00
····
····
····
····
····
····
····
SG&A Expenses
$90.6M
$90.4M
$97.2M
$95.1M
····
····
····
····
····
····
····
Operating Expenses
-$444.7M
$90.4M
$1.15B
$845.0M
····
····
····
····
····
····
····
EBITDA
$1.75B
$1.44B
$1.61B
$1.27B
····
····
····
····
····
····
····
Operating Income
$519.5M
$544.1M
$471.2M
$433.9M
····
····
····
····
····
····
····
Interest Expense
$337.0M
$305.2M
$280.4M
$200.3M
····
····
····
····
····
····
····
Income Before Tax
$278.5M
$110.3M
$271.7M
$325.1M
····
····
····
····
····
····
····
Income Tax Expense
$3.7M
$9.3M
$4.3M
-$9.6M
····
····
····
····
····
····
····
Net Income
$253.7M
$71.3M
$243.1M
$306.0M
····
····
····
····
····
····
····
Basic EPS
$0.35
$0.10
$0.36
$0.56
····
····
····
····
····
····
····
Basic Shares
690M
696M
676M
547M
····
····
····
····
····
····
····
Diluted Shares
690M
696M
676M
547M
····
····
····
····
····
····
····
Upgrade to Premium for up to 10 annual periods, where available.
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
Margins expanded
Cash position grew
What Weakened
Debt increased
Potential Score Impact
Positive indicators included revenue growth, EPS growth, cash levels, net income margin. Pressure indicators included debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 11.1%. EPS increased 76.2%. Cash increased 1719.0%. Total debt increased 10.4%. Net income margin improved by 3.6 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Upgrade to Premium to unlock all earnings history.View plans
Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.
Dividend HistoryShare
Dividend History
Log in to view dividend history.
Log In
Predictions & Historical PerformanceShare
Conservative Projected Values
3 Years
$———.——
Premium
5 Years
$———.——
Premium
10 Years
$———.——
Premium
Conservative Projection Rate
——%
Premium
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.